Papers (English)
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe, Figure
Supplementary Materials, Figure S1 and FigureS2
What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions Figure S1
COVID-19 vaccination-related myocarditis: a Korean nationwide study, Figure 1
A SYSTEMATIC REVIEW OF AUTOPSY FINDINGS IN DEATHS AFTER COVID-19 VACCINATION, Figure 4
Time-Dependent Changes in Death Reports and the Sex Ratio in the Safety Surveillance of SARS-CoV-2 Vaccination in Japan, the United States, and European Countries, Figures 1, 2 , 5, and 6
Analysis of the Association Between BNT162b2 mRNA COVID-19 Vaccination and Deaths Within 10 Days After Vaccination Using the Sex Ratio in Japan, Figures 1 and 2
Importance of Examining Incidentality in Vaccine Safety Assessment, Figures 1, 2 and 3
IReview of Calls for Market Removal of COVID-19 Vaccines Intensify: Risks Far Outweigh Theoretical Benefits, Figure 1
Papers (Japanese)
COVID-19ワクチン接種後の死亡と薬剤疫学的評価の概要：全国民ベースの概観と提案，Fig. 2, Fig. 3
新型コロナウイルスワクチン接種者及び全医療関係者への警告と要請～新型コロナウイルスワクチン接種後5日目に心筋の横紋筋融解症によって突然死亡した28歳健常男性の事例をもとに Fig. 1
新型コロナワクチン接種後の大動脈解離：症例と厚生労働省への死亡報告，そして文献的考察 Fig. 5
Others (English)
From Senator Ron Johnson's page
VAERS Summary for COVID-19 Vaccines through 4/30/2021
Others (Japanese)
第53 回厚生科学審議会予防接種・ワクチン分科会副反応検討部会，令和2 年度第13 回薬事・食品衛生審議会薬事分科会医薬品等安全対策部会安全対策調査会（合同開催）．新型コロナワクチンの投与開始初期の重点的調査（コホート調査）；1 回目接種後健康観察日誌集計の中間報告．2021（令和3）年3 月12日，７，８，９ページ目
米CDCによるコロナワクチン副反応解析の隠蔽疑惑
コロナワクチン接種後心筋炎の救済認定及びα評価の現状とChatGPTによる集計
コロナワクチン接種後の死亡データ、自動グラフ化に成功
50歳未満接種後死亡の接種1回目と2回目では、死亡メカニズムが異なる可能性がある
新型コロナのエビデンス, (2023.7.10), (2023.5.1), (2023.4.17), (2023.4.3)